Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
RGEN [NASD]
Repligen Corporation
Index- P/E38.40 EPS (ttm)0.50 Insider Own3.20% Shs Outstand32.65M Perf Week2.73%
Market Cap626.88M Forward P/E53.33 EPS next Y0.36 Insider Trans9.31% Shs Float30.68M Perf Month0.10%
Income16.30M PEG- EPS next Q0.04 Inst Own85.90% Short Float13.87% Perf Quarter-5.51%
Sales66.10M P/S9.48 EPS this Y11.10% Inst Trans5.14% Short Ratio10.40 Perf Half Y23.63%
Book/sh3.59 P/B5.35 EPS next Y28.57% ROA13.60% Target Price24.33 Perf Year92.58%
Cash/sh1.53 P/C12.51 EPS next 5Y- ROE15.20% 52W Range9.84 - 24.68 Perf YTD40.76%
Dividend- P/FCF32.99 EPS past 5Y22.70% ROI15.40% 52W High-22.20% Beta1.25
Dividend %- Quick Ratio6.90 Sales past 5Y18.30% Gross Margin62.50% 52W Low95.12% ATR0.90
Employees116 Current Ratio8.40 Sales Q/Q-10.90% Oper. Margin33.10% RSI (14)43.99 Volatility4.31% 3.93%
OptionableYes Debt/Eq0.00 EPS Q/Q-35.70% Profit Margin24.70% Rel Volume0.48 Prev Close18.58
ShortableYes LT Debt/Eq0.00 EarningsAug 11 BMO Payout0.00% Avg Volume409.23K Price19.20
Recom1.00 SMA20-2.57% SMA50-9.41% SMA20012.16% Volume195,283 Change3.34%
07-Mar-11Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
30-Jun-09Initiated Merriman Buy
12-Jun-08Reiterated Rodman & Renshaw Mkt Outperform $11 → $9
10-Sep-07Reiterated Rodman & Renshaw Mkt Outperform $6 → $8
12-Apr-07Reiterated Rodman & Renshaw Mkt Outperform $5 → $6
19-Aug-14 01:04PM  REPLIGEN CORP Financials EDGAR Online Financials
18-Aug-14 11:07AM  REPLIGEN CORP Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi EDGAR Online +6.73%
11-Aug-14 07:28AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q2 2014 Repligen Corporation Earnings Release - Before Market Open CCBN
07:00AM  Repligen Reports Second Quarter 2014 Financial Results GlobeNewswire
28-Jul-14 07:30AM  Repligen to Report Second Quarter 2014 Financial Results GlobeNewswire
15-Jul-14 03:17PM  CFO Moves: Repligen Corp., Top Image Systems Ltd. at The Wall Street Journal
07:51AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat EDGAR Online
07:30AM  Repligen Hires Jon K. Snodgres as Chief Financial Officer GlobeNewswire
02-Jul-14 01:48PM  3 Stocks to Get on Your Watchlist at Motley Fool
01-Jul-14 05:05PM  On The Fly: Closing Wrap at theflyonthewall.com
27-Jun-14 08:17AM  Repligen (RGEN) Shares March Higher, Can It Continue? Zacks
08:17AM  Repligen (RGEN) Shares March Higher, Can It Continue?
12-Jun-14 09:52AM  Repligen Appoints Nicolas M. Barthelemy to Board of Directors GlobeNewswire
09:52AM  Repligen Appoints Nicolas M. Barthelemy to Board of Directors
08:05AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
08:05AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04-Jun-14 03:22PM  Why Repligen Corporation Shares Vaulted Higher at Motley Fool +6.89%
03:22PM  Why Repligen Corporation Shares Vaulted Higher
03-Jun-14 09:00AM  Repligen Corp Conference Call to discuss the acquisition of Bioprocessing Business of Refine Technology scheduled for 9:00 am ET today CCBN
08:01AM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositio EDGAR Online
08:01AM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositio
07:00AM  Repligen Acquires Bioprocessing Business of Refine Technology GlobeNewswire
07:00AM  Repligen Acquires Bioprocessing Business of Refine Technology
28-May-14 04:15PM  Repligen to Present at Jefferies 2014 Global Healthcare Conference GlobeNewswire
04:15PM  Repligen to Present at Jefferies 2014 Global Healthcare Conference
19-May-14 06:37PM  Should a Soaring Market Cap Worry Repligen Corporation Investors? at Motley Fool
06:37PM  Should a Soaring Market Cap Worry Repligen Corporation Investors?
12:12PM  Repligen management to meet with Jefferies at theflyonthewall.com
12:12PM  Repligen management to meet with Jefferies
08:01AM  REPLIGEN CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matt EDGAR Online
08:01AM  REPLIGEN CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matt
16-May-14 01:04PM  REPLIGEN CORP Financials EDGAR Online Financials
01:04PM  REPLIGEN CORP Financials
11-May-14 04:35PM  Surges In Biotech Short Interest (INCY, PCYC, RGEN) Benzinga
09-May-14 11:10AM  REPLIGEN CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
08-May-14 01:52PM  Why Repligen Corporation Shares Briefly Spiked Higher at Motley Fool
08:30AM  Repligen Corporation Earnings Call scheduled for 8:30 am ET today CCBN
07:46AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:34AM  Repligen Corporation Earnings Call scheduled for 8:30 am ET today CCBN
07:17AM  Repligen backs FY14 revenue view $54M-$57M, consensus $55.2M at theflyonthewall.com
07:15AM  Repligen reports Q1 EPS 13c, consensus 9c at theflyonthewall.com
07:07AM  Q1 2014 Repligen Corporation Earnings Release - Before Market Open CCBN
07:00AM  Repligen Reports First Quarter 2014 Financial Results GlobeNewswire
06-May-14 07:10AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat EDGAR Online
03-May-14 12:29PM  Repligen: A Strong Investment For The Right Kind Of Investor at Seeking Alpha
25-Apr-14 02:03PM  Repligen to Report First Quarter 2014 Financial Results GlobeNewswire
19-Apr-14 12:48PM  3 Humongous Health-Care Stocks This Week at Motley Fool
15-Apr-14 05:53PM  Repligen Corporation Set to Join the S&P SmallCap 600 PR Newswire +5.12%
08-Apr-14 08:05AM  3 Stocks Spiking on Unusual Volume at TheStreet
26-Mar-14 07:30AM  Repligen Launches OPUS(R) Ready-to-Use Chromatography Columns With Largest Capacity Available on the Market GlobeNewswire
21-Mar-14 08:31AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
19-Mar-14 01:04PM  REPLIGEN CORP Financials EDGAR Online Financials
14-Mar-14 11:51AM  REPLIGEN CORP Files SEC form 10-K, Annual Report EDGAR Online
06-Mar-14 01:53PM  Why Repligen Corporation Shares Were Slammed at Motley Fool -8.52%
01:53PM  Why Repligen Corporation Shares Were Slammed
10:40AM  Repligen Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
10:40AM  Repligen Management Discusses Q4 2013 Results - Earnings Call Transcript
09:00AM  Repligen Corporation Earnings Call scheduled for 9:00 am ET today CCBN
08:01AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:30AM  Repligen Reports Full Year and Fourth Quarter 2013 Financial Results GlobeNewswire
07:07AM  Q4 2013 Repligen Corporation Earnings Release - Before Market Open CCBN
25-Feb-14 07:30AM  Repligen to Report Fourth Quarter and Fiscal Year 2013 Financial Results GlobeNewswire
22-Jan-14 06:37PM  Lightning Round: Caterpillar, LinkedIn & More at CNBC +8.86%
04:26PM  Why Repligen Corporation Shares Jumped at Motley Fool
04:26PM  Why Repligen Corporation Shares Jumped
21-Jan-14 03:03PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and EDGAR Online
03:03PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and
11:12AM  Repligen, Continuing Overhaul, Flips Rare Disease Drugs to BioMarin at Motley Fool
11:12AM  Repligen, Continuing Overhaul, Flips Rare Disease Drugs to BioMarin
07:30AM  Repligen Announces Asset Purchase Agreement With BioMarin for HDACi Portfolio GlobeNewswire
07:30AM  Repligen Announces Asset Purchase Agreement With BioMarin for HDACi Portfolio
20-Jan-14 02:12PM  Apples To Apples: Organovo Vs. Repligen at Seeking Alpha
02:12PM  Apples To Apples: Organovo Vs. Repligen
12-Jan-14 07:08AM  How Will the Bottom Line Change for Repligen in 2014? at Motley Fool
07:08AM  How Will the Bottom Line Change for Repligen in 2014?
10-Jan-14 11:42AM  How Will the Top Line Change for Repligen in 2014? at Motley Fool
11:42AM  How Will the Top Line Change for Repligen in 2014?
01-Jan-14 12:03PM  3 Health Care Investments Immune From FDA Scrutiny at Motley Fool
12:03PM  3 Health Care Investments Immune From FDA Scrutiny
13-Dec-13 10:08AM  What Should Investors Expect From Repligen in 2014? at Motley Fool
10:08AM  What Should Investors Expect From Repligen in 2014?
05-Dec-13 10:04PM  Fundamentally Attractive Biotechnology "Pick & Shovel" Companies at Seeking Alpha
10:04PM  Fundamentally Attractive Biotechnology "Pick & Shovel" Companies
26-Nov-13 07:30AM  Repligen to Present at the 25th Annual Piper Jaffray Healthcare Conference GlobeNewswire
07:30AM  Repligen to Present at the 25th Annual Piper Jaffray Healthcare Conference
24-Nov-13 01:55PM  Repligen-My Projections For The Income Statement: 2013 -2019 at Seeking Alpha
01:55PM  Repligen - My Projections For The Income Statement: 2013-2019 at Seeking Alpha
01:55PM  Repligen - My Projections For The Income Statement: 2013-2019
22-Nov-13 02:01PM  5 Biotech Trends Powering Repligen's Growth at Motley Fool
02:01PM  5 Biotech Trends Powering Repligen's Growth
19-Nov-13 04:48PM  The Simplest Biotech Growth Portfolio Ever at Motley Fool
04:48PM  The Simplest Biotech Growth Portfolio Ever
04:12PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
04:12PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
02:58PM  Repligen names Biogen executive to its board AP
02:58PM  Repligen names Biogen executive to its board
02:00PM  Repligen Appoints Biogen Idec Executive John G. Cox to Board of Directors GlobeNewswire
17-Nov-13 08:46PM  Repligen's 3 Most Important Customers at Motley Fool
15-Nov-13 11:04AM  What the End of Bristol-Myers Squibb Royalties Means for Repligen at Motley Fool
Repligen Corporation, a life sciences company, develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. The company manufactures various forms of Protein A, a critical reagent used in biomanufacturing to separate and purify monoclonal antibodies. It also supplies various growth factor products, which are used to increase cell growth and productivity during upstream fermentation. In addition, the company manufactures and sells chromatography products, including OPUS pre-packed columns for biologics purification, as well as proprietary Protein A media and quality test kits. Further, it has a portfolio of therapeutic product candidates, which include RG3039, a small molecule drug candidate in clinical development for spinal muscular atrophy; histone deacetylase inhibitor for the treatment of Friedreich's ataxia disease; and RG1068, a synthetic human hormone developed as a novel imaging agent for the detection of pancreatic duct abnormalities in combination with magnetic resonance imaging in patients with pancreatitis and other related diseases. Additionally, Repligen Corporation offers alternating tangential flow system, a filtration device used to improve product yields during the fermentation step of the biologic drug manufacturing process. The company sells its bioprocessing products are to various life sciences companies, biopharmaceutical manufacturing companies, and contract manufacturing organizations worldwide. Repligen Corporation was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Benjamin HowardVP Business DevelopmentAug 13Option Exercise3.335,00016,650113,851Aug 14 04:26 PM
Benjamin HowardVP Business DevelopmentAug 13Sale20.3440,000813,79273,851Aug 14 04:26 PM
RYAN THOMAS F JRDirectorJun 27Option Exercise4.1310,00041,30055,312Jul 01 08:12 AM
RYAN THOMAS F JRDirectorJun 27Sale22.4110,000224,13050,312Jul 01 08:12 AM
RYAN THOMAS F JRDirectorJun 24Option Exercise4.9610,00049,60060,312Jun 25 02:04 PM
RYAN THOMAS F JRDirectorJun 24Sale21.7810,000217,78050,312Jun 25 02:04 PM
WITT DANIEL PSenior Vice PresidentJun 20Option Exercise4.9087,500428,62580,833Jun 24 09:38 AM
HERLIHY WALTER CPRESIDENT, CEOJun 11Sale20.1160,3351,213,584539,477Jun 12 04:09 PM
RUSCHE JAMES RSenior Vice PresidentJun 09Sale20.1930,000605,730121,270Jun 10 12:09 PM
WITT DANIEL PSenior Vice PresidentJun 06Sale20.5647,709980,70610,000Jun 09 01:36 PM
RYAN THOMAS F JRDirectorJun 05Option Exercise4.7245,000212,20070,312Jun 09 03:56 PM
Benjamin HowardVP Business DevelopmentJun 05Option Exercise4.40102,036448,853115,962Jun 09 01:35 PM
RYAN THOMAS F JRDirectorJun 05Sale20.5645,000925,08850,312Jun 09 03:56 PM
RUSCHE JAMES RSenior Vice PresidentApr 15Buy3.0525,00076,250151,270Apr 15 04:53 PM
WITT DANIEL PSenior Vice PresidentApr 15Buy3.0510,00030,50057,709Apr 15 04:51 PM